Novartis Partners with Generate in $1B Biotech Deal

Novartis Enters Billion-Dollar Biotech Deal with Generate

In a groundbreaking move, Novartis has signed a $1 billion-plus deal with Generate:Biomedicines, a company founded by Flagship Pioneering. This agreement aims to develop protein therapeutics for various medical conditions. While specific diseases have not been disclosed, the partnership is described as a "multi-target collaboration".